Idenix Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference

CAMBRIDGE, Mass., Sept. 28  /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) announced today that management will present a corporate overview at the upcoming JMP Securities Healthcare Focus Conference on Monday, October 5, 2009 at 8:30 a.m. ET at The New York Palace Hotel.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at http://www.idenix.com/.  Please log in approximately 5-10 minutes before the event to ensure a timely connection.  The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com/.

Idenix Pharmaceuticals Contact:

Teri Dahlman [phone] 

DATASOURCE: Idenix Pharmaceuticals, Inc.



CONTACT:  Teri Dahlman, [phone]



Web Site:  http://www.idenix.com/ 

Copyright